Por favor, use este identificador para citar o enlazar este ítem: http://sgc.anlis.gob.ar/handle/123456789/1951
Campo DC Valor Lengua/Idioma
dc.contributor.authorEnria, Deliaes
dc.contributor.authorBriggiler, Ana M.es
dc.contributor.authorSánchez, Zaidaes
dc.date.accessioned2020-12-18T16:02:56Z-
dc.date.available2020-12-18T16:02:56Z-
dc.date.issued2008-04-
dc.identifier.issn0166-3542-
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144853/pdf/main.pdf-
dc.identifier.urihttp://sgc.anlis.gob.ar/handle/123456789/1951-
dc.descriptionFil: Enria, Delia. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Virales Humanas; Argentina.es
dc.descriptionFil: Briggiler, Ana M. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Virales Humanas; Argentina.es
dc.descriptionFil: Sánchez, Zaida. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Virales Humanas; Argentina.es
dc.description.abstractArgentine hemorrhagic fever (AHF) is a rodent-borne illness caused by the arenavirus Junin that is endemic to the humid pampas of Argentina. AHF has had significant morbidity since its emergence in the 1950s, with a case-fatality rate of the illness without treatment between 15% and 30%. The use of a live attenuated vaccine has markedly reduced the incidence of AHF. Present specific therapy involves the transfusion of immune plasma in defined doses of neutralizing antibodies during the prodromal phase of illness. However, alternative forms of treatment are called for due to current difficulties in early detection of AHF, related to its decrease in incidence, troubles in maintaining adequate stocks of immune plasma, and the absence of effective therapies for severely ill patients that progress to a neurologic-hemorrhagic phase. Ribavirin might be a substitute for immune plasma, provided that the supply is guaranteed. Immune immunoglobulin or monoclonal antibodies should also be considered. New therapeutic options such as those being developed for systemic inflammatory syndromes should also be valuated in severe forms of AHF.es
dc.language.isoenes
dc.publisherElsevieres
dc.relation.ispartofAntiviral researches
dc.rightsClosed Access-
dc.subjectFiebre Hemorrágica Americanaes
dc.subjectArenaviruses
dc.titleTreatment of Argentine hemorrhagic feveres
dc.typeArtículoes
dc.identifier.doi10.1016/j.antiviral.2007.10.010-
item.cerifentitytypePublications-
item.openairetypeArtículo-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptAdministración Nacional de Laboratorios e Institutos de Salud “Dr. Carlos G. Malbrán” (ANLIS)-
crisitem.author.deptInstituto Nacional de Enfermedades Virales Humanas (INEVH)-
crisitem.author.parentorgAdministración Nacional de Laboratorios e Institutos de Salud “Dr. Carlos G. Malbrán” (ANLIS)-
Aparece en las colecciones: Publicaciones INEVH
Mostrar el registro sencillo del ítem

Visualizaciones de página(s)

91
comprobado en 15-ago-2025

Google ScholarTM

Consultar

Altmetric

Altmetric


Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.